Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Vetoquinol SA (Vetoquinol), a subsidiary of Soparfin SCA, is a veterinary pharmaceutical company. It develops, produces, and distributes veterinary drugs and non-medicinal products for cats, dogs, cattle, and pigs. The company offers products in therapy areas which include pain, hygiene and care, dermatology, reproduction, mobility and inflammation, udder health, cardio-nephrology and behaviour management. It also offers diagnostics, digital applications, and services. The company distributes its products under brands such as Tolfedine CS, Clindaseptin, Aurizon, Oridermyl, Longamox, and Pen-Histra-Strep, among others. It offers its products to customers, veterinarians, breeders, and pet owners in Europe, the Americas, Africa, the Middle East, Asia and Oceania. Vetoquinol is headquartered in Lure, France.

Gain a 360-degree view of Vetoquinol SA and make more informed decisions for your business Gain a 360-degree view of Vetoquinol SA and make more informed decisions for your business Register your interest
Headquarters France

Address 34 Rue du Chene Sainte-Anne, Magny-Vernois, Lure, Haute Normandie, 70204


Telephone 33 3 84625555

No of Employees 2,497

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange VETO (EPA)

Revenue (2024) $593.1M -2.5% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ -2.3% (2024 vs 2023)

Market Cap* $980.6M

Net Profit Margin (2024) XYZ 0.3% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Vetoquinol SA premium industry data and analytics

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Vetoquinol SA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Domains: Tolfedine CS
Mobility, Pain, and Inflammation Dolpac
Dermatology, Hygiene & Care Zylkene
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Vetoquinol SA portfolio and identify potential areas for collaboration Understand Vetoquinol SA portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Vetoquinol SA Zoetis Inc Elanco Animal Health Inc Virbac SA Ceva Sante Animale SA
Headquarters France United States of America United States of America France France
City Lure Parsippany Indianapolis Carros Libourne
State/Province Haute Normandie New Jersey Indiana Provence - Alpes- Cote d'Azur Aquitaine
No. of Employees 2,497 14,500 9,400 6,442 7,000
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Matthieu Frechin Director; Chief Executive Officer; President Executive Board 2023 57
Dominique Derveaux Chief Operating Officer; Director Executive Board 2009 57
Alain Masson Director; Pharmacist Manager; Deputy Chief Executive Officer Executive Board - 64
Regis Vimal du Monteil Chief Financial Officer Senior Management - -
Sandrine Perrier Chief Information Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Vetoquinol SA key executives to enhance your sales strategy Gain insight into Vetoquinol SA key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?